Combination therapy for gonorrhoea: in vitro synergy testing | Zendy

Rui P. A. Pereira | Zendy; Michelle Cole | Zendy; C A Ison | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Combination therapy for gonorrhoea: in vitro synergy testing

Author(s) -

Rui P. A. Pereira,

Michelle Cole,

C A Ison

Publication year - 2012

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dks449

Subject(s) - cefixime , azithromycin , gentamicin , antimicrobial , ceftriaxone , neisseria gonorrhoeae , agar dilution , medicine , minimum inhibitory concentration , microbiology and biotechnology , antibiotics , pharmacology , biology

Antimicrobial resistance in Neisseria gonorrhoeae is an increasing problem worldwide and combinations of antimicrobial agents have been recommended to delay the onset of treatment failures. The objective of this study was to obtain in vitro data on the activity of current (ceftriaxone or cefixime plus azithromycin) and alternative (gentamicin plus azithromycin) regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research